Corebridge Financial Inc (CRBG) experienced a decline of 5.03% during regular trading, hitting a 5-day low. This drop comes amid broader market weakness, with the Nasdaq-100 down 1.48% and the S&P 500 down 0.88%.
The recent news indicates that Corebridge Financial will replace Allete in the S&P MidCap 400 effective December 17, 2025. This inclusion is expected to enhance its market visibility and attract institutional investor interest, despite the current market conditions. The acquisition of Allete by the Canada Pension Plan Investment Board and Global Infrastructure Partners is nearing completion, which may impact market confidence in the utilities sector.
The implications of this index change suggest that Corebridge Financial's recognition within the financial sector is growing, potentially leading to increased liquidity and visibility for its stock. However, the current market environment has led to a decline in its stock price, indicating a sector rotation as investors reassess their positions.
Wall Street analysts forecast CRBG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CRBG is 37.30 USD with a low forecast of 33.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
Wall Street analysts forecast CRBG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CRBG is 37.30 USD with a low forecast of 33.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
3 Hold
0 Sell
Moderate Buy
Current: 30.380
Low
33.00
Averages
37.30
High
40.00
Current: 30.380
Low
33.00
Averages
37.30
High
40.00
Barclays
Alex Scott
Overweight
downgrade
$39 -> $35
2026-01-08
Reason
Barclays
Alex Scott
Price Target
$39 -> $35
AI Analysis
2026-01-08
downgrade
Overweight
Reason
Barclays analyst Alex Scott lowered the firm's price target on Corebridge to $35 from $39 and keeps an Overweight rating on the shares. The firm is "cautiously optimistic" on life insurers heading into 2026, saying capital strength, cash flow, and consolidation offset headwinds like spread compression and technology spend. Barclays adjusted ratings and price targets as part of its 2026 outlook.
UBS
Neutral
downgrade
$35 -> $33
2026-01-08
Reason
UBS
Price Target
$35 -> $33
2026-01-08
downgrade
Neutral
Reason
UBS lowered the firm's price target on Corebridge to $33 from $35 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CRBG
Unlock Now
BofA
Joshua Shanker
Buy
downgrade
$40 -> $39
2026-01-05
Reason
BofA
Joshua Shanker
Price Target
$40 -> $39
2026-01-05
downgrade
Buy
Reason
BofA analyst Joshua Shanker lowered the firm's price target on Corebridge to $39 from $40 and keeps a Buy rating on the shares. As in 2025, the pricing trends for most P&C insurance products do not appear positive, the analyst tells investors in a research note. While pricing for liability lines remains positive, it seems that loss costs are rising more steeply than prices, the analyst says, adding that personal auto rates are flattish, while some investors are expecting decline in response to high profitability. The firm added, however, that underwriter valuations hardly look expensive, even as fundamentals have tipped in the "wrong direction."
JPMorgan
Neutral
downgrade
$40 -> $39
2026-01-05
Reason
JPMorgan
Price Target
$40 -> $39
2026-01-05
downgrade
Neutral
Reason
JPMorgan lowered the firm's price target on Corebridge to $39 from $40 and keeps a Neutral rating on the shares. The firm adjusted ratings and targets in the life insurance space as part of its 2026 outlook. JPMorgan's outlook for life insurance stocks is positive. The analyst sees a favorable macro backdrop, "healthy" balance sheets, and an expected improvement in operating results. Deterioration in high-grade corporate credit "presents a key risk to a bullish stance on life stocks," contends the firm.
About CRBG
Corebridge Financial, Inc. is a provider of retirement solutions and insurance products in the United States. The Company partners with financial professionals and institutions to help individuals plan, save for and achieve secure financial futures. Its Individual Retirement segment consists of fixed annuities, fixed index annuities, registered index-linked annuities and variable annuities. Its Group Retirement segment consists of recordkeeping, plan administrative and compliance services, financial planning and advisory solutions offered in-plan, along with proprietary and limited non-proprietary annuities, advisory and brokerage products offered out-of-plan. Its Life Insurance segment consists of term and universal life insurance products in the United States. Its Institutional Markets segment consists of stable value wrap (SVW) products, structured settlement and pension risk transfer (PRT) annuities, guaranteed investment contracts (GICs) and corporate markets products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
